Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III

被引：30

作者：

Grob, Jean Jacques ^{[1
,2
]}

Schadendorf, Dirk ^{[3
,4
]}

Lorigan, Paul ^{[5
]}

Ascierto, Paolo ^{[6
]}

Larkin, James ^{[7
]}

Nathan, Paul ^{[8
]}

Robert, Caroline ^{[9
]}

Hauschild, Axel ^{[10
]}

Weber, Jeffrey ^{[11
]}

Daud, Adil ^{[12
]}

Hamid, Omid ^{[13
]}

Dummer, Reinhard ^{[14
]}

Hansson, Johan ^{[15
]}

Hoeller, Christoph ^{[16
]}

Schachter, Jacob ^{[17
]}

Van Akkooi, Alexander C. J. ^{[18
]}

Garbe, Claus ^{[19
]}

机构：

[1] Aix Marseille Univ, Marseille, France

[2] Univ Hosp Marseille, AP HM, Marseille, France

[3] Univ Essen Gesamthsch, Heidelberg, Germany

[4] German Canc Consortium, Heidelberg, Germany

[5] Univ Manchester, Christie Natl Fdn Trust Manchester, Manchester, Lancs, England

[6] Fdn G Pascale, Ist Nazl Tumori, Naples, Italy

[7] Royal Marsden Hosp, London, England

[8] Mt Vernon Canc Ctr, Northwood, Middx, England

[9] Gustave Roussy & Paris Sud Univ, Paris, France

[10] Univ Klinikum Schleswig Holstein, Kiel, Germany

[11] NYU, Laura & Isaac Perlmutter Canc Ctr, Med, New York, NY USA

[12] Univ Calif San Francisco, San Francisco, CA 94143 USA

[13] Angeles Clin & Res Inst, Los Angeles, CA USA

[14] Univ Zurich, Zurich, Switzerland

[15] Karolinska Univ Hosp Solna, Stockholm, Sweden

[16] Med Univ Vienna, Vienna, Austria

[17] Sheba Med Ctr Tel Hashomer, Ella Lemelbaum Inst Immunooncol, Div Oncol, Ramat Gan, Israel

[18] Netherlands Canc Inst, Amsterdam, Netherlands

[19] Univ Hosp Tuebingen, Tubingen, Germany

来源：

EUROPEAN JOURNAL OF CANCER | 2018年 / 91卷

关键词：

D O I：

10.1016/j.ejca.2017.11.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：168 / 170

页数：3

共 5 条

[1]

Faries MB, 2017, N ENGL J MED, V376

[2] Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual [J].

Gershenwald, Jeffrey E. ;

Scolyer, Richard A. ;

Hess, Kenneth R. ;

Sondak, Vernon K. ;

Long, Georgina V. ;

Ross, Merrick I. ;

Lazar, Alexander J. ;

Faries, Mark B. ;

Kirkwood, John M. ;

McArthur, Grant A. ;

Haydu, Lauren E. ;

Eggermont, Alexander M. M. ;

Flaherty, Keith T. ;

Balch, Charles M. ;

Thompson, John F. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) :472-492

[3] Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial [J].

Leiter, Ulrike ;

Stadler, Rudolf ;

Mauch, Cornelia ;

Hohenberger, Werner ;

Brockmeyer, Norbert ;

Berking, Carola ;

Sunderkoetter, Cord ;

Kaatz, Martin ;

Schulte, Klaus-Werner ;

Lehmann, Percy ;

Vogt, Thomas ;

Ulrich, Jens ;

Herbst, Rudolf ;

Gehring, Wolfgang ;

Simon, Jan-Christoph ;

Keim, Ulrike ;

Martus, Peter ;

Garbe, Claus .

LANCET ONCOLOGY, 2016, 17 (06) :757-767

[4] Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma [J].

Long, G. V. ;

Hauschild, A. ;

Santinami, M. ;

Atkinson, V. ;

Mandala, M. ;

Chiarion-Sileni, V. ;

Larkin, J. ;

Nyakas, M. ;

Dutriaux, C. ;

Haydon, A. ;

Robert, C. ;

Mortier, L. ;

Schachter, J. ;

Schadendorf, D. ;

Lesimple, T. ;

Plummer, R. ;

Ji, R. ;

Zhang, P. ;

Mookerjee, B. ;

Legos, J. ;

Kefford, R. ;

Dummer, R. ;

Kirkwood, J. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19) :1813-1823

[5] Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma [J].

Weber, J. ;

Mandala, M. ;

Del Vecchio, M. ;

Gogas, H. J. ;

Arance, A. M. ;

Cowey, C. L. ;

Dalle, S. ;

Schenker, M. ;

Chiarion-Sileni, V. ;

Marquez-Rodas, I. ;

Grob, J-J. ;

Butler, M. O. ;

Middleton, M. R. ;

Maio, M. ;

Atkinson, V. ;

Queirolo, P. ;

Gonzalez, R. ;

Kudchadkar, R. R. ;

Smylie, M. ;

Meyer, N. ;

Mortier, L. ;

Atkins, M. B. ;

Long, G. V. ;

Bhatia, S. ;

Lebbe, C. ;

Rutkowski, P. ;

Yokota, K. ;

Yamazaki, N. ;

Kim, T. M. ;

de Pril, V. ;

Sabater, J. ;

Qureshi, A. ;

Larkin, J. ;

Ascierto, P. A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19) :1824-1835

← 1 →